Performance of polyoxymethylene plastic (POM) as a component of a tissue engineering bioreactor

Journal of Biomedical Materials Research - Part A

Volumn 75, Issue 1, 2005, Pages 168-174

  Penick, Kitsie J ^a   Solchaga, Luis A ^a   Berilla, Jim A ^a   Welter, Jean F ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chondrocytes; Delrin; Mesenchymal stem cells; Polyacetal

Indexed keywords

CELLS; FILLERS; FORMALDEHYDE; RESINS; TISSUE; WETTING;

CHONDROCYTES; DELRIN; MESENCHYMAL STEM CELLS; POLYACETAL; POLYOXYMETHLYENE PLASTIC (POM);

BIOREACTORS;

FORMALDEHYDE; POLYMER; POLYOXYMETHYLENE; UNCLASSIFIED DRUG;

ARTICLE; AUTOCLAVE; BIOREACTOR; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TYPE; CHONDROGENESIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMPLANT; MESENCHYMAL STEM CELL; POLYMERIZATION; THERMOSTABILITY; TISSUE ENGINEERING;

ACETALS; BIOCOMPATIBLE MATERIALS; BIOREACTORS; CARTILAGE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CHONDROCYTES; CULTURE MEDIA; CULTURE MEDIA, CONDITIONED; FORMALDEHYDE; HEAT; HUMANS; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELLS; PLASTICS; POLYMERS; RESINS, SYNTHETIC; SENSITIVITY AND SPECIFICITY; STEM CELLS; TIME FACTORS; TISSUE ENGINEERING;

EID: 24744462097     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.a.30351     Document Type: Article

References (26)

1. Baskaran H, Solchaga L, Penick K, Berilla J, Welter J. Substrate mass transport in tissue engineered cartilage. In: Hoffner L, editor. Proceedings of the Arthritis Research Conference; Arthritis Foundation, Atlanta, GA, 2003. p 2.32.
2. Solchaga L, Tognana E, Goldberg V, Caplan A, Welter J. Tissue engineered cartilage implants: in vitro chondrogenic pre-conditioning. Proceedings of the 4th Symposium of the International Cartilage Repair Society 2003:271.
3. Welter J, Penick K, Berilla J, Caplan A, Goldberg VM, Solchaga L. MSC-based Tissue engineered cartilage: Effects of construct assembly method and perfusion rates. In: Hoffner L, editor. Proceedings of the Arthritis Research Conference; Arthritis Foundation, Altanta, GA 2003. p 2.33.
4. USFDA. 21CFR177.2480 Polyoxymethylene homopolymer. Code Fed Regul 2002;3:331-332.
5. Laluppa JA, McAdams TA, Papoutsakis ET, Miller WM. Culture materials affect ex vivo expansion of hematopoietic progenitor cells. J Biomed Mater Res 1997;36:347-359.
6. Björk VO. Delrin as implant material for valve occluders. Scand J Thorac Cardiovasc Surg 1972;6:103-107.
7. Björk VO. A new tilting disc valve prosthesis. Scand J Thorac Cardiovasc Surg 1969;3:1-10.
8. MacAfee KA, Quinn PD. Total temporomandibular joint reconstruction with a Delrin titanium implant. J Craniofac Surg 1992;3:160-169.
9. Fister JS, Memoli VA, Galante JO, Rostoker W, Urban RM. Biocompatibility of Delrin 150: a creep-resistant polymer for total joint prostheses. J Biomed Mater Res 1985;19:519-533.
10. Brown SA, Mayor MB. The biocompatibility of materials for internal fixation of fractures. J Biomed Mater Res 1978;12:67-82.
11. Buch F, Albrektsson T, Herbst E. Effects of direct currents on bone growth into delrin implants. Scand J Plast Reconstr Surg 1985;19:223-230.
12. Havelin LI, Gjerdet NR, Lunde OD, Rait M, Sudmann E. Wear of the Christiansen hip prosthesis. Acta Orthopaed Scand 1986; 57:419-422.
13. Agnihotri N, Kisaalita WS, Keith CH. Micro-perfusion flow cell for imaging cultured cells. Biotechniques 1999;27:722-726, 728.
14. Abdullah LH, Davis SW, Burch L, Yamauchi M, Randell SH, Nettesheim P, Davis CW. P2u purinoceptor regulation of mucin secretion in SPOC1 cells, a goblet cell line from the airways. Biochem J 1996;316:943-951.
15. Lennon DP, Haynesworth SE, Young RG, Dennis JE, Caplan AI. A chemically defined medium supports in vitro proliferation and maintains the osteochondral potential of rat marrow-derived mesenchymal stem cells. Exp Cell Res 1995;219:211-222.
16. Johnstone B, Hering TM, Caplan AI, Goldberg VM, Yoo JU. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 1998;238:265-272.
17. Lennon DP, Haynesworth SE, Bruder SP, Jaiswal N, Caplan AI. Human and animal mesenchymal progenitor cells from bone marrow: Identification of serum for optimal selection and proliferation. In Vitro Cell Dev Biol 1996;32:602-611.
18. Haynesworth SE, Goshima J, Goldberg VM, Caplan AI. Characterization of cells with osteogenic potential from human marrow. Bone 1992;13:81-88.
19. Ballock RT, Reddi AH. Thyroxine is the serum factor that regulates morphogenesis of columnar cartilage from isolated chondrocytes in chemically defined medium. J Cell Biol 1994; 126:1311-1318.
20. Yoo JU, Barthel TS, Nishimura K, Solchaga L, Caplan AI, Goldberg VM, Johnstone B. The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J Bone Joint Surg Am 1998;80:1745-1757.
21. Allay JA, Dennis JE, Haynesworth SE, Majumdar MK, Clapp DW, Shultz LD, Caplan AI, Gerson SL. LacZ and interleukin-3 expression in vivo after retroviral transduction of marrow-derived osteogenic mesenchymal progenitors. Hum Gene Ther 1997;8:1417-1427.
22. Lennon DP, Haynesworth SE, Arm DM, Baber MA, Caplan AI. Dilution of human mesenchymal stem cells with dermal fibroblasts and the effects on in vitro and in vivo osteochondrogenesis. Dev Dyn 2000;219:50-62.
23. Tsutsumi S, Shimazu A, Miyazaki K, Pan H, Kolke C, Yoshida E, Takagishi K, Kato Y. Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem Biophys Res Commun 2001;288:413-419.
24. Mastrogiacomo M, Cancedda R, Quarto R. Effect of different growth factors on the chondrogenic potential of human bone marrow stromal cells. Osteoarthritis and Cartilage 2001; 9(Suppl A):S36-40.
25. Solchaga L, Penick K, Welter J. A "manual" mosaicking approach to generating large, high-resolution digital images of histological sections. Proc Royal Microsc Soc 2004;39:313-320.
26. Lijoi A, Parodi E, Passerone GC. An old Delrin tilting disc: eroded but strong. Tex Heart Inst J 2001;28:232.